18th Annual European Life Sciences CEO Forum

FOR PARTNERING & INVESTMENT

26th - 27th of February 2025|HILTON ZURICH AIRPORT HOTEL | SWITZERLAND

Attendees:

+ND Capital

3B Future Health Ventures

4BIO Capital

4C Biomed Inc.

AAA Family Office

AATec Medical GmbH

Abalos Therapeutics GmbH

AbbVie, Inc.

abcDNA GmbH

ActiTrexx GmbH

Adare Pharma Solutions

Adoram Therapeutics SA

AFK & Partners Asset Management LLC

AIRNA Corporation, Inc.

Aixial UK Ltd

Alder Therapeutics AB

Alkapharmics SARL

Alpioner Therapeutics

Alviv Laser Solutions

AM-Pharma B.V.

Amarna Therapeutics B.V.

Amazon Web Services

Ampleia

Amplitude Ventures

Amporin Pharmaceuticals AG

AMR Action Fund GP GmbH

Angelini Ventures S.p.A.

Anixa Biosciences, Inc.

ANNIMO Health EDC AG

Anocca AB

Antabio SAS

Apollo Health Ventures

ARCH Venture Partners

ARCHIMED

Arphamid Therapeutics GmbH

ARTCLINE GmbH

Asahi Kasei Ventures

Ascension Ventures

ATGN Consulting

Atheneos Ventures LLC

Aurealis Therapeutics AG

AurorA Science Srl

Avance Basel GmbH

Avata Biosciences Ltd.

AVEROA SAS

b2venture GmbH

BaseLaunch

Baylink Biosciences

Bergmann zur Hausen & Cie. GmbH

Berlin Partner für Wirtschaft und Technologie GmbH

BGV

Bio Med Gene Ventures

BioInvent International AB

BioMedPartners AG

BiomedVC AG

Biopôle SA

Bioqube Ventures

Bioscience Equity Partners

BIOSTART Consulting GmbH

biotx.ai GmbH

Biovision Ventures

BiPER Therapeutics

Bird & Bird LLP

BlackRock

Bloomberg

Bloomberg Intelligence

BlueSky Immunotherapies GmbH

Boehringer Ingelheim International GmbH

BOHE Angel Fund

Bootstrap Europe

Bpifrance

brainQr Therapeutics GmbH

BROTHERS & Partners Europe

Business Angels Switzerland

Calida Therapeutics SAS

Cancer Research Horizons

CARMA FUND Management GmbH

Caszyme, LLC

Cbio A/S

CDR-Life AG

CELLnTEC Advanced Cell Systems

Centenara

CH Consulting Group

CIS BIOPHARMA AG

Clavyst Bio Singapore

Cleara Biotech

CNS Pharmaceuticals, Inc.

Cohesion Bureau

Conscience Medicines Network

Convergence Partners

Convert Pharmaceuticals SA

Corden Pharma International Switzerland LLC

Coulter Partners

Cube Labs SpA

Cukierman & Co. Investment House Ltd.

Cukierman & Co. Life Sciences

Cumulus Oncology Ltd.

Curie.Bio

Debiopharm International SA

Delin Ventures Ltd.

Dementia Discovery Fund 2 L.P. (SV Health Investors)

Digital Networks PLC

Dimericon Therapeutics AG

EA Pharma Co., Ltd.

Eight Roads Ventures

Eli Lilly and Company

Eliraz Ventures

Elpiscience Biopharmaceuticals Co. Ltd.

Elypta

EMRIS Pharma

Engimmune Therapeutics AG

EpimAb Biotherapeutics

EQT Life Sciences

ESC Advisors

European Investment Bank

European Investment Fund

Evariste

Evernow Publishing Ltd, publisher of MedNous

Evox Therapeutics Ltd

Exact Sciences Corporation

F. Hoffmann-La Roche AG

FamiCordTx S.A.

FatiAbGen International GmbH

FimmCyte AG

Flerie AB

FluoSphera SA

Fontaine Capital

Forbion

Forty51 Ventures AG

Forvis Mazars

FoRx Therapeutics AG

Fraser Partners

FreeMind Group

Galimedix Therapeutics, Inc.

Genchrome

Generation Fund Life Sciences Fund I

Genius Search GmbH & Co. KG

GenSearch Switzerland GmbH

GETEC Platform Switzerland

GIBF

Gimv

Global Lifescience Ventures

GOLDTRACK Ventures GmbH

GrowthCube Partners

GSK

H. Lundbeck A/S

H.C. Wainwright & Co., LLC

HBM Partners AG

Health Care Advisory

Health Innovation Capital

HeartBeat.bio AG

Heidelberg Pharma AG

Helbling Technik Bern AG

HEPHAISTOS Pharma

HHC Medical

High-Tech Gründerfonds Management GmbH

HighLight Capital

HK Family Office Business

Hong Kong Trade Development Council

Humanitas Research Hospital

ICF Consult Switzerland

Igyxos

Immunyx Pharma

In Virtuo Laboratories SAGL

Innovent Biologics

Innovestor Life Science

Inovotion

InSphero AG

Integra Therapeutics

Intract Pharma Ltd.

Inveready Asset Management S.G.E.I.C., S.A.

InvestHK

invIOs GmbH

iOmx Therapeutics AG

IPF Partners

Italian Angels for Growth (IAG)

J.P. Morgan

JFG Life Sciences Foundation

Johnson & Johnson Innovation LLC

KBI Biopharma, Inc.

Kerna Ventures

King Bioventures

Kurma Partners

Landmark Angels/Family Ofiice

Landmark BioVentures

Laverock Therapeutics Ltd.

Lead Pharma

Leads To Development

leap:up GmbH

LifeCare Partners GmbH

LightOx Ltd.

Limani Partners

LimmaTech Biologics AG

LMU Munich

Lumira Ventures

Lyophitech

M&G Advisors GmbH

M2Care

Mabylon AG

Macomics Ltd.

MC Services AG

MCE Carrel Avocats SA

Medicover AB

MEDiSTRAVA

MEDKAP Investor Association

Memo Therapeutics AG

Mergermarket

Mestag Therapeutics Ltd.

MetrioPharm AG

Mewburn Ellis LLP

MicThera SAGL

Mid Atlantic Bio Angels

Midland Pharmaceuticals

Mighto Therapeutics

Minoryx Therapeutics

Mirabaud & Cie SA

Modi VC

Momentum Biotech LLC

MSQ Ventures

NatIgGs GmbH

NEC Bio B.V.

NEOM

New Harbor Venture Partners, LLC

Nextech Invest Ltd.

NG Bio

NGT Healthcare II

NLC – The European Healthtech Venture Builder BV

Novartis AG

Novartis Venture Fund

Novo Holdings A/S

NRW.Venture

NxR Biotechnologies

Octopus Ventures

Omega Funds

OmnilinX Therapeutics

OncoBone Therapeutics Ltd

Oncode Accelerator

One Therapeutics Assets Limited (OTAL)

OrbiMed Advisors LLC

Orikine Bio

Oxford Science Enterprises

Pace Ventures

Palleos Healthcare GmbH

PannTheraPi

Peppermint Venture Partners GmbH

Perogative LLC

Pfizer, Inc.

Pharmell Life Sciences SA

PhoreMost Ltd.

Pictet & Cie SA

Pleco Therapeutics BV

Procavea Biotech AG

Pureos Bioventures

Qiming Venture Partners

Quant Biomarkers AG

Rahim Invest

Rambam AG

Recolony AG

Reconnect Labs AG

Recordati Pharma GmbH

Recordati S.p.A.

Redalpine Venture Partners AG

RedHill Biopharma Ltd.

RedZinc Services Ltd

Resolution Therapeutics

River BioMedics B.V.

RNATICS GmbH

Roche Venture Fund

Rosetta Capital Ltd.

Roy Consulting

RV Invest

Salvina Therapeutics AG

Sanara Ventures

Sanofi

Sapreme Technologies BV

Sarcura GmbH

Scarlet Therapeutics Limited

Schwarz Financial Communication

Scius Communications

Seamless Therapeutics, Inc.

Secarna Pharmaceuticals GmbH & Co. KG

Seekyo Tx

Seqens

Serenatis Bio

Seventure Partners

Slate Therapeutics LTD

Sobi

Sofinnova Partners

Solgate GmbH

Sound Bioventures

Spago Nanomedical AB

SpikImm SARL

SpyBiotech Inc.

Staatz Business Development & Strategy

Sterne, Kessler, Goldstein & Fox PLLC

Stifel

STIMIT AG

Stromal Therapeutics AG

Swiss Biotech Association

Swiss Broadcasting Corporation (swissinfo.ch)

Switchkine SA

Symeres B.V.

Synklino A/S

T-knife Therapeutics, Inc.

Taiho Ventures, LLC

Tamedia Finanz und Wirtschaft AG

TargImmune Therapeutics AG

TC BioPharm Limited

Telum Therapeutics SL

Thabor Therapeutics

The Fulford Group Ltd.

Thermosome GmbH

Tigermed

TILT Biotherapeutics Ltd.

TME Pharma

TOLREMO Therapeutics AG

Torrey Pines Investment

TransCure bioServices SAS

Trialize AG

Truffle Capital

TruVenturo GmbH

Tuari Therapeutics GmbH

Turenne Capital

UBS AG

UCEA Capital Group

Umlaut.bio GmbH

University Hospital of Zürich

University of Lausanne

University of Zurich

USI Startup Centre

VALANX Biotech GmbH

Valor Management

VasoDynamics Ltd.

Vectiopep

Venture Valuation VV AG

Versant Ventures

VI Partners AG

ViaNautis Bio Ltd.

Vidac Pharma Holding PLC

Viopas Venture Consulting

Vitarka Therapeutics Ltd

Vogel BioC

WBB Securities

Wellington Partners

XGEN Venture SGR S.p.A.

XYone Therapeutics Inc.

YAYA Capital

Ysios Capital

Last updated: March 27, 2025